In the current study, we set out to establish if LINC00858 affected the progression of colon cancer and revealed that LINC00858 could recruit RAD21 to regulate PCNP-mediated STAT3/5 signaling pathway, thereby promoting the development of colon cancer. Here, RAD21 is linked to malignant colon neoplasm.